Wendy H. Chern

651 total citations
13 papers, 519 citations indexed

About

Wendy H. Chern is a scholar working on Dermatology, Oncology and Molecular Biology. According to data from OpenAlex, Wendy H. Chern has authored 13 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Wendy H. Chern's work include Nonmelanoma Skin Cancer Studies (3 papers), Cutaneous Melanoma Detection and Management (3 papers) and Cannabis and Cannabinoid Research (2 papers). Wendy H. Chern is often cited by papers focused on Nonmelanoma Skin Cancer Studies (3 papers), Cutaneous Melanoma Detection and Management (3 papers) and Cannabis and Cannabinoid Research (2 papers). Wendy H. Chern collaborates with scholars based in United States, Taiwan and France. Wendy H. Chern's co-authors include Kailas Thakker, Pahala Simamora, Sharon Levy, Katharine Furst, Joel E. Shaffer, James Hubbell, William R. Garnett, William A. Wargin, John M. Pellock and W.C. Dauterman and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Journal of Investigative Dermatology.

In The Last Decade

Wendy H. Chern

13 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy H. Chern United States	11	112	107	97	83	79	13	519
Giovanna Cipolla Italy	13	159 1.4×	67 0.6×	176 1.8×	12 0.1×	30 0.4×	19	541
Hsiu‐Ying Yu Taiwan	13	133 1.2×	38 0.4×	76 0.8×	132 1.6×	8 0.1×	37	481
Thomas Birngruber Austria	15	25 0.2×	133 1.2×	16 0.2×	154 1.9×	91 1.2×	48	781
Jinping Wang China	13	42 0.4×	12 0.1×	51 0.5×	29 0.3×	100 1.3×	38	508
Tarek Ibrahim United States	22	494 4.4×	25 0.2×	35 0.4×	228 2.7×	41 0.5×	77	1.3k
Hye‐Rim Shin South Korea	17	26 0.2×	31 0.3×	33 0.3×	10 0.1×	102 1.3×	54	848
Margarida Duarte‐Araújo Portugal	12	16 0.1×	22 0.2×	21 0.2×	60 0.7×	30 0.4×	30	418
E. Marttin Netherlands	9	32 0.3×	55 0.5×	14 0.1×	529 6.4×	22 0.3×	12	781
Fangfang He China	13	27 0.2×	14 0.1×	24 0.2×	37 0.4×	34 0.4×	38	832
J. T. Burke France	10	48 0.4×	24 0.2×	40 0.4×	11 0.1×	23 0.3×	15	379

Countries citing papers authored by Wendy H. Chern

Since Specialization

Citations

This map shows the geographic impact of Wendy H. Chern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy H. Chern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy H. Chern more than expected).

Fields of papers citing papers by Wendy H. Chern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy H. Chern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy H. Chern. The network helps show where Wendy H. Chern may publish in the future.

Co-authorship network of co-authors of Wendy H. Chern

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy H. Chern. A scholar is included among the top collaborators of Wendy H. Chern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy H. Chern. Wendy H. Chern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Uang, Yow‐Shieng, et al.. (2017). Pharmacokinetics of dinalbuphine sebacate and nalbuphine in human after intramuscular injection of dinalbuphine sebacate in an extended‐release formulation. Biopharmaceutics & Drug Disposition. 38(8). 494–497. 20 indexed citations

Chern, Wendy H., et al.. (2017). In vitro and in vivo release of dinalbuphine sebacate extended release formulation: Effect of the oil ratio on drug release. International Journal of Pharmaceutics. 531(1). 306–312. 13 indexed citations

Johnston, Michael, et al.. (2007). Effects of Topically Applied Acitretin in Reconstructed Human Epidermis and the Rhino Mouse. Journal of Investigative Dermatology. 128(1). 125–130. 21 indexed citations

Hofland, Hans, et al.. (2007). Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges. Toxicologic Pathology. 35(7). 853–864. 10 indexed citations

Simamora, Pahala & Wendy H. Chern. (2006). Poly-L-lactic acid: an overview.. PubMed. 5(5). 436–40. 65 indexed citations

Thakker, Kailas & Wendy H. Chern. (2003). Development and Validation of In Vitro Release Tests for Semisolid Dosage Forms—Case Study. Dissolution Technologies. 10(2). 10–15. 86 indexed citations

Levy, Sharon, Katharine Furst, & Wendy H. Chern. (2002). A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.. PubMed. 70(2 Suppl). 14–21. 7 indexed citations

Levy, Sharon, Katharine Furst, & Wendy H. Chern. (2001). A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis. Clinical Therapeutics. 23(6). 908–920. 46 indexed citations

Levy, Sharon, Katharine Furst, & Wendy H. Chern. (2001). A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clinical Therapeutics. 23(6). 901–907. 36 indexed citations

10.

Shaffer, Joel E., et al.. (1992). Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 286–293. 56 indexed citations

11.

Pellock, John M., et al.. (1991). Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy. Epilepsy Research. 10(2-3). 191–200. 114 indexed citations

12.

Chern, Wendy H., et al.. (1990). Determination of albuterol concentrations in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 8(7). 591–596. 31 indexed citations

13.

Chern, Wendy H. & W.C. Dauterman. (1983). Studies on the metabolism and excretion of 1-naphthol, 1-naphthyl-β-d-glucuronide, and 1-naphthyl-β-d-glucoside in the mouse. Toxicology and Applied Pharmacology. 67(3). 303–309. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact